- Home
- BNT vs NBIX Comparison
BNT vs NBIX Comparison
Compare BNT & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BNT | NBIX |
|---|---|---|
| Founded | 2020 | 1992 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8B | 13.9B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | BNT | NBIX |
|---|---|---|
| Price | $40.56 | $129.26 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 22 |
| Target Price | N/A | ★ $175.27 |
| AVG Volume (30 Days) | 25.2K | ★ 1.2M |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | ★ 0.69% | N/A |
| EPS Growth | N/A | ★ 41.95 |
| EPS | N/A | ★ 4.67 |
| Revenue | N/A | ★ $161,626,000.00 |
| Revenue This Year | N/A | $22.85 |
| Revenue Next Year | N/A | $9.99 |
| P/E Ratio | ★ $19.14 | $27.38 |
| Revenue Growth | N/A | ★ 977.51 |
| 52 Week Low | $40.60 | $84.23 |
| 52 Week High | $74.16 | $160.18 |
Technical Indicators
Market Signals| Indicator | BNT | NBIX |
|---|---|---|
| Relative Strength Index (RSI) | 33.11 | 44.86 |
| Support Level | N/A | $129.17 |
| Resistance Level | $47.95 | $136.74 |
| Average True Range (ATR) | 1.19 | 3.01 |
| MACD | -0.40 | 0.10 |
| Stochastic Oscillator | 3.13 | 28.93 |
Price Performance
Historical ComparisonAbout BNT Brookfield Wealth Solutions Ltd.
Brookfield Wealth Solutions Ltd, formerly Brookfield Reinsurance Ltd operates a capital solutions business providing insurance and reinsurance services to individuals and institutions. Through its subsidiary, the company offers a broad range of insurance products and services, including life insurance and annuities, and personal and commercial property and casualty insurance. It is organized into three reporting segments: Direct Insurance, Reinsurance, and Pension Risk Transfer (PRT).
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.